Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest Feature Articles

jp-kress_mor

Working Life Interview: Jean-Paul Kress, CEO of MorphoSys

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Working Life, feature, morphosys, pharma

With a medical doctorate as well as degrees in pharmacology and immunology under your belt, was your path always to …

Feature
insider_interview_andrew_roach

A new weapon against Parkinson’s-related psychosis

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Parkinson's disease, cannabidiol, cannabis, feature, pharma

Dr Arthur Roach, Director of Research at the charity Parkinson’s UK, discusses new trials on cannabidiol in the treatment of …

Feature
shutterstock_138095450

Transactions in the pharma sector: Through the EU merger review looking-glass

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | EU, feature, mergers & acquisitions, pharma

With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) …

Feature
image3

Patient experience: Living with desmoid fibromatosis

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | desmoid fibrosis, feature, patient experience, pharma, rare disease

Lisa Pascoe lives with a rare, benign desmoid tumour in her abdomen. She opens up to Pharmafocus on her diagnosis …

Feature
sang-jin_pak

Exclusive interview: Samsung Bioepis’ Sang-Jin Pak on the rise of biosimilars

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Samsung Bioepis, biosimilars, pharma

Following on from our focus on biosimilars in our feature last week, you can read Nikhil Patel’s interview with Sang-Jin …

Feature

The coming age of biosimilars

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | biosimilars, feature, pharma

With more and more biosimilars securing approval and the sheer potential value they have to offer for healthcare systems around …

Feature
capture

Bringing the clinical trial home

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | clinical trials, feature, research

Clinical trials are the backbone of healthcare and drug research, but many key patient populations have in the past been …

Feature

Working Life Interview: Alison Muir, Oncology Product Strategy Director at Roche

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Roche, Working Life, feature, pharma

You studied biology at Liverpool John Moores University before heading straight to GSK in 1990 as a Sales Representative; was …

Feature

Redefining the value of medicines with patients at the centre

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Takeda, health economics and outcomes research, market access, pharma

Liz Lewis, Head of Global Oncology Patient Value, Policy and Access at Takeda Oncology, discusses the importance and challenges of …

Feature
shutterstock_273326141

Transactions in the pharma sector: Through the EU merger review looking-glass

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | mergers, mergers and acquisitions, pharma

With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) …

Feature
222170359

Damage control: How will pharma manage the health economic impacts of Brexit?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | HEOR, brexit, health economics and outcomes research, pharma

When it comes to life sciences and patient outcomes, the UK’s destiny is inextricably tied to its relationship with the …

Feature
brexit-hintergrund_web

“No deal” Brexit and life sciences: What happens?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | EU, Europe, UK, brexit, no deal, no-deal, pharma

Prime Minister Boris Johnson may have agreed a withdrawal agreement with the European Union at the 11th hour, but despite …

Feature

Medical cannabis: Growth by leaps and bounds

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Canada, Canopy Growth, medical cannabis, pharma

This article follows parts one and two of our trio of in-depth pieces focusing on the growing medical cannabis phenomenon. …

Feature
_dsc6281_1

Medical cannabis: Riding the wave

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Kanabo research, medical cannabis, pharma

Following on from our previous piece from Mewburn Ellis on the history of social attitudes towards cannabis, Israel-based Kanabo Research …

Feature
_dsc6538

Medical cannabis: On to greener pastures?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | medical cannabis, medicinal cannabis, pharma

In the first of three articles on the topic, Callum McGuinn, Associate and European Patent Attorney at Mewburn Ellis, explores …

Feature
Load more Feature Articles
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025